Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 30 to 75

Eszopiclone for lowering blood pressure in adults with insomnia and high blood pressure

Official title: Impact of Eszopiclone on Blood Pressure in Patients With Insomnia and Hypertension (PRYSMA-HTN)

Run by University of Sao Paulo · NCT07018557 · Data updated 2026-11-12

This study tests whether eszopiclone can improve sleep and lower 24-hour ambulatory blood pressure in adults aged 30–75 who have insomnia and treated hypertension.

More Hypertension trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages30 Years to 75 Years
SexAll
Enrollment150 (estimated)
SponsorUniversity of Sao Paulo
Academic / other
Locations1 site (São Paulo, São Paulo)
StatusRecruiting
StartedJune 4, 2025
Main results expectedJune 1, 2026
Study endsDecember 31, 2026
Registry record updatedJune 12, 2025
Trial IDNCT07018557 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 30–75 years old with treated high blood pressure (systolic 130–160 mmHg, diastolic 80–100 mmHg), BMI <40 kg/m2, and insomnia who can attend clinic visits and are not using benzodiazepines or 'Z' drugs are ideal candidates.

Probably not a fit

Patients with severe COPD, heart failure with reduced ejection fraction, prior stroke, severe psychiatric disorders, advanced kidney disease, decompensated diabetes, active cancer, pregnancy, current benzodiazepine/'Z' drug use, or shift work are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with treated hypertension will be screened for insomnia and undergo baseline questionnaires and portable sleep apnea monitoring. After a one‑month run‑in period to confirm adherence and baseline blood pressure, eligible participants will be randomized in a double‑blind fashion to sleep hygiene plus eszopiclone 3 mg or sleep hygiene plus placebo for three months. The primary outcome is change in 24‑hour ambulatory blood pressure, with secondary outcomes including daytime/nighttime BP changes, non‑dipping status, office BP, and multiple validated sleep and mood scales. Demographic, anthropometric, comorbidity, and medication data will also be collected at baseline and after three months.

Why it matters

Potential benefit: If successful, this could offer a way to improve sleep and modestly reduce 24‑hour blood pressure in patients with insomnia and hypertension.

How similar studies have gone: Observational studies link insomnia to higher blood pressure, but randomized double‑blind trials testing hypnotic medications like eszopiclone on 24‑hour ambulatory blood pressure are limited, so this approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults (30 to 75 years-old)
* BMI \<40Kg/m2;
* Availability to participate
* History of HBP under regular treatment (systolic pressure between 130-160 and diastolic pressure between 80-100 mmHg).

Exclusion Criteria:

* Use of benzodiazepines or "Z" drugs;
* Night workers;
* History of severe chronic obstructive pulmonary disease (COPD);
* Heart failure (ejection fraction \<40% on echocardiogram);
* Prior stroke;
* Generalized anxiety disorder (GAD-7 \>14 points) and severe depression (Beck);
* Severe liver disease;
* Alcohol abuse;
* Advanced chronic kidney disease 4 or 5 (glomerular filtration rate \<30ml/min/1.73m2);
* Patient who is on loop diuretics;
* Patient with type 1 diabetes;
* Patient with decompensated type 2 diabetes (Glycated hemoglobin \>10%);
* Urinuria Incontinence;
* Prostatism;
* History of active cancer;
* Pregnancy;
* Complex sleep behaviors, suicidal behavior.

Where it's running

  • Academic Research Organization - Heart Institute (InCor)
    São Paulo, São Paulo, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Sleep and arterial function in hypertensive patients with poor sleep quality

    This trial tests whether using cognitive-behavioural therapy for insomnia can improve artery health and well-being in adults with high blood pressure and poor sleep.

    Recruiting Unidade Local de Saúde do Alto Ave, EPE · Guimarães, Braga District · NCT07789535

  • Using low-dose aspirin after preeclampsia to improve recovery

    This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.

    Recruiting Phase 4 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT06281665

  • Understanding how drugs work in children

    This study is trying to find the best and safest doses of certain medications for children and young adults under 21 who are being treated for conditions like COVID-19 and pulmonary arterial hypertension.

    Recruiting at 5 sites Duke University · Phoenix, Arizona and 51 other locations · NCT04278404

  • SleepCogni for children with chronic insomnia

    A handheld SleepCogni device is tested to see if it helps kids aged 6–16 with chronic insomnia sleep better.

    Recruiting Sheffield Children's NHS Foundation Trust · Sheffield · NCT07926724

  • Music therapy after stroke

    This trial tests whether adding music therapy to standard care helps stroke patients sleep better and feel less anxious or depressed while in the hospital.

    Recruiting Universidad de Granada · Granada, Granada · NCT07899034

  • IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension

    This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.

    Recruiting at 8 sites Bahir Dar University · Ādēt and 7 other locations · NCT07894068

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.